Published in Contemp Oncol (Pozn) on January 01, 2015
Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis. Oncotarget (2016) 0.82
Renal Cancer Stem Cells: Characterization and Targeted Therapies. Stem Cells Int (2016) 0.80
Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential. Nitric Oxide (2015) 0.77
Functional significance of CD105-positive cells in papillary renal cell carcinoma. BMC Cancer (2017) 0.77
Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma. J Cancer Res Clin Oncol (2016) 0.75
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet (2014) 5.74
Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res (2002) 5.00
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res (2009) 4.36
CD133: molecule of the moment. J Pathol (2008) 3.58
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood (2005) 3.51
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood (2004) 3.41
Intratumor heterogeneity: seeing the wood for the trees. Sci Transl Med (2012) 3.38
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res (2003) 3.25
Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells (2005) 3.00
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res (2008) 2.82
Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells (2004) 2.80
Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells (2011) 2.75
The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev (2011) 2.56
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One (2011) 2.49
Chemokines in cancer. Cytokine Growth Factor Rev (2002) 2.47
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res (2010) 2.39
ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev (2010) 2.07
Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic (2001) 2.03
Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer (2013) 1.92
Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J (2008) 1.88
Cancer stem cell and cancer stemloids: from biology to therapy. Cancer Biol Ther (2007) 1.74
Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle (2010) 1.73
Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res (2005) 1.68
Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. BJU Int (2013) 1.59
Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun (2007) 1.57
Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol (2001) 1.55
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J (2000) 1.50
CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol (2006) 1.36
Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci (2004) 1.32
Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol (1992) 1.31
Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol (1992) 1.28
The Walter Herbert Lecture. Control of cell motility and tumour invasion by extracellular matrix interactions. Br J Cancer (1992) 1.27
Stage- and segment-specific expression of cell-adhesion molecules N-CAM, A-CAM, and L-CAM in the kidney. Kidney Int (1993) 1.26
Expression of NCAM recapitulates tubulogenic development in kidneys recovering from acute ischemia. Am J Physiol (1999) 1.22
Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer (2010) 1.13
Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line. PLoS One (2013) 1.11
Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms. Biochim Biophys Acta (2013) 1.08
The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS One (2011) 1.02
A novel role for the chemokine receptor Cxcr4 in kidney morphogenesis: an in vitro study. Dev Dyn (2009) 1.00
Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. J Surg Oncol (2013) 0.99
Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine. Cell Tissue Res (2006) 0.99
Immunohistochemical analysis of neural cell adhesion molecules. Differential expression in small round cell tumors of childhood and adolescence. Am J Pathol (1991) 0.97
Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma. Arch Pathol Lab Med (2007) 0.95
Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior. Hum Pathol (2003) 0.94
Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. J Urol (2005) 0.94
High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. World J Surg Oncol (2012) 0.94
Cancer stem cells and their role in metastasis. Pharmacol Ther (2013) 0.93
Targeted therapy in metastatic renal carcinoma. Cancer Lett (2013) 0.93
High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis. Oncol Lett (2011) 0.92
Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma. Oncol Rep (2008) 0.87
Tissue-based molecular markers for renal cell carcinoma. Minerva Urol Nefrol (2011) 0.86
Immunologics and chemotherapeutics for renal cell carcinoma. Semin Intervent Radiol (2014) 0.85
Finding markers for cancer stem cells in renal cell carcinoma: looking beyond CD133. Cell Cycle (2010) 0.85
Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer. Arch Ital Urol Androl (2012) 0.84
Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis. Hum Pathol (2011) 0.84
Tumor initiating cells. Curr Pharm Biotechnol (2009) 0.83
Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells. Anticancer Res (2005) 0.83
CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma. World J Urol (2011) 0.83
Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma. Histol Histopathol (2013) 0.82
CD133+ cells as a therapeutic target for kidney diseases. Expert Opin Ther Targets (2012) 0.82
Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study. World J Surg Oncol (2013) 0.80
Expression of CD44 and P53 in renal cell carcinoma: association with tumor subtypes. Saudi J Kidney Dis Transpl (2014) 0.78
CXCR4 expression during tumour cell death. Leuk Res (2006) 0.78
Expression of neural cell adhesion molecule in renal cell carcinoma. Acta Chir Iugosl (2012) 0.76
[Prognostic value of the expression of adhesion molecules for non-clear-cell variants of renal cell carcinoma]. Arkh Patol (2013) 0.76
Development of chronic myeloid leukaemia in patients treated with anti-VEGF therapies for clear cell renal cell cancer. Future Oncol (2015) 0.77
The use of sunitinib in renal cell carcinoma: where are we now? Expert Rev Anticancer Ther (2014) 0.75
Triiodothyronine regulates cell growth and survival in renal cell cancer. Int J Oncol (2016) 0.75